In practice, that flexibility means pivoting packaging sourcing across global regions when tariffs reshape the math, without giving up the quality the professionals who use the products expect. It also means a clear rule on where to invest: Innovate relentlessly, and don’t chase trends.
Science over fashion: HydroPeptide focuses on regenerative aesthetics that deliver measurable results, not on whatever’s popular at the moment.The right outside technology: Rather than become a device company, HydroPeptide forms strategic relationships with proven, validated devices and builds treatment protocols around them, elevating patients’ experiences and outcomes.The professional as North Star: Every decision routes back to the aestheticians, nurse practitioners and dermatologists the brand serves.
And her approach means building a banking relationship that can keep up with a multinational consumer-products business growing on its own terms.
The banking relationship behind the decisions
HydroPeptide, headquartered in the Seattle area, is private equity-backed and growing internationally. Rubin’s local J.P. Morgan banker brings deep beauty-industry experience and convenes specialists from across the firm—and connections from across the beauty industry—when HydroPeptide’s leadership team is weighing strategic moves.